APP下载

高尔基体蛋白73、甲胎蛋白、甲胎蛋白异质体3%联合检测对

2016-10-19诸琴红

中国医药导报 2016年5期
关键词:原发性肝癌

诸琴红

[摘要] 目的 探討高尔基体蛋白73、甲胎蛋白、甲胎蛋白异质体3%联合检测对原发性肝癌的诊断价值。 方法 选取浙江省德清县第三人民医院(以下简称“我院”)2011年1月~2015年6月收治的100例原发性肝癌患者作为原发性肝癌组,选取我院同期收治的100例良性肝脏疾病患者作为内部对照组,选取我院同期健康体检者100名作为外部对照组。甲胎蛋白采用放射免疫法检测,高尔基体蛋白73、甲胎蛋白异质体3%采用酶联免疫吸附测定(ELISA)法检测。观察三组研究对象高尔基体蛋白73、甲胎蛋白水平、甲胎蛋白异质体3%;甲胎蛋白不同水平者高尔基体蛋白73阳性率;高尔基体蛋白73、甲胎蛋白、甲胎蛋白异质体3%对原发性肝癌诊断的敏感性、特异性情况。 结果 原发性肝癌组高尔基体蛋白73[(175.8±51.4)μg/L]、甲胎蛋白[(2125.1±566.8)μg/L]、甲胎蛋白异质体3%[(15.5±5.8)%]均明显高于内部对照组[(82.5±32.5)μg/L、(83.8±34.4)μg/L、(8.4±3.2)%]和外部对照组[(16.5±13.4)μg/L、(10.2±4.3)μg/L、(6.2±0.9)%],内部对照组高尔基体蛋白73、甲胎蛋白水平、甲胎蛋白异质体3%均高于外部对照组,差异均有统计学意义(P < 0.05)。原发性肝癌组、内部对照组、外部对照组研究对象在甲胎蛋白≤200 μg/L时的高尔基体蛋白73阳性率(2%、4%、0%)差异无统计学意义(P > 0.05),原发性肝癌组在甲胎蛋白>200~300 μg/L、>300~400 μg/L、>400 μg/L时高尔基体蛋白73阳性率(4%、6%、59%)均明显高于内部对照组(0、0、0)和外部对照组(0、0、0),三项指标联合检测对原发性肝癌诊断的敏感性(96%)、特异性(99%)均高于单一高尔基体蛋白73检测的81%和93%、单一甲胎蛋白检测的63%和91%、单一甲胎蛋白异质体3%检测的78%和85%,差异均有统计学意义(P < 0.05)。 结论 高尔基体蛋白73、甲胎蛋白、甲胎蛋白异质体3%联合检测对原发性肝癌具有较高的敏感性和特异性,为原发性肝癌的临床诊断和治疗提供了可靠的理论依据。

[关键词] 高尔基体蛋白73;甲胎蛋白;甲胎蛋白异质体3%;原发性肝癌;诊断价值

[中图分类号] R735.7 [文献标识码] A [文章编号] 1673-7210(2016)02(b)-0130-04

Diagnostic value of joint detection of golgin 73, alpha-fetoprotein, alpha-fetoprotein variants for primary hepatocellular carcinoma

ZHU Qinhong

Department of Laboratory, Deqing County Third People's Hospital, Zhejiang Province, Deqing 313201, China

[Abstract] Objective To approach the diagnostic value of joint detection of golgin 73 (GP73), alpha-fetoprotein (AFP), alpha-fetoprotein variants (AFP-L3%) for primary hepatocellular carcinoma. Methods One hundred cases of patients with primary hepatocellular carcinoma admitted to Deqing County Third People's Hospital ("our hospital" for short) from January 2011 to June 2015 were selected as primary hepatocellular carcinoma group, 100 cases of patients with benign liver diseases admitted to our hospital at the same period were selected as internal control group, 100 cases of persons for physical examination in our hospital at the same period were selected as external control group. The AFP was detected by radioimmunoassay, GP73, AFP-L3% were detected by enzyme-linked immuno sorbent assay (ELISA). The GP73, AFP, AFP-L3% of three groups, the GP73 positive rate of different levels of AFP, the sensibility and specificity of GP73, AFP, AFP-L3% for diagnosis of primary hepatocellular carcinoma were observed. Results The GP73 [(175.8±51.4) μg/L], AFP [(2125.1±566.8) μg/L], AFP-L3% [(15.5±5.8)%] of primary hepatocellular carcinoma group were higher than those of internal control group [(82.5±32.5) μg/L, (83.8±34.4) μg/L, (8.4±3.2)%] and external control group [(16.5±13.4) μg/L, (10.2±4.3) μg/L, (6.2±0.9)%], the GP73, AFP, AFP-L3% of internal control group were higher than those of external control group, the differences were all statistically significant (P < 0.05). The GP73 positive rates of primary hepatocellular carcinoma group, internal control group, external control group (4%, 6%, 59%) in the AFP ≤200 μg/L had no statistically significant differences (P > 0.05). The GP73 positive rates of primary hepatocellular carcinoma group (4%, 6%, 59%) in the AFP >200-300 μg/L, >300-400 μg/L, >400 μg/L were higher than those of internal control group (0, 0, 0) and external control group (0, 0, 0), the sensibility (96%), specificity (99%) of joint detection of three indicators for diagnosis of primary hepatocellular carcinoma were higher than single GP73 detection (81% and 93%), single AFP detection (63% and 91%), single AFP-L3% detection (78% and 85%), the differences were all statistically significant (P < 0.05). Conclusion The joint detection of GP73, AFP, AFP-L3% has higher sensibility and specificity for diagnosis of primary hepatocellular carcinoma, which can provide reliable theory basis for clinical diagnosis and treatment of primary hepatocellular carcinoma.

[Key words] Golgin 73; Alpha-fetoprotein; Alpha-fetoprotein variants; Primary hepatocellular carcinoma; Diagnostic value

原发性肝癌属于人体消化系统常见的恶性肿瘤,其中有95……

登录APP查看全文

猜你喜欢

原发性肝癌
三维适形半野轮照放疗技术治疗局部晚期原发性肝癌的临床疗效
消癌平片联合TACE术治疗老年原发性肝癌的疗效和生命质量的临床观察
贝伐单抗联合肝动脉化疗栓塞术对36例晚期原发性肝癌生存预后的影响分析
TACE序贯3D—CRT治疗原发性肝癌的疗效及安全性观察
探析介入治疗中晚期原发性肝癌破裂出血的安全性观察
不同血流阻断法在原发性肝癌手术中的效果分析
超声造影在腹腔镜射频消融治疗原发性肝癌中的效果
GP73、AFP 异质体联合检测在原发性肝癌早期诊断中的应用进展
腹腔镜肝切除治疗原发性肝癌的疗效观察
介入治疗在原发性肝癌中的应用